Lv11
40 积分 2021-12-31 加入
Silent burden: recognising and managing invisible symptoms in neuromyelitis optica
4小时前
求助中
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis
24天前
已关闭
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
1个月前
已完结
Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study
1个月前
已完结
Transitioning immunotherapy in neuromyelitis optica spectrum disorder – when and how to switch
1个月前
已完结
Diagnosis and Management of Children With Atypical Neuroinflammation
1个月前
已完结
Blood-Based Biomarkers for Identifying Disease Activity in AQP4-IgG–Positive Neuromyelitis Optica Spectrum Disorder
1个月前
已完结
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C
1个月前
已关闭
Eculizumab in AQP4-IgG NMOSD
2个月前
已完结
Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders
3个月前
已完结
皖公网安备34019202002308
